Warren Buffett, the CEO of Berkshire Hathaway, has donated $6 billion in Berkshire stock to five charities. This is his ...

The move will likely solidify the foundation’s outsized role in global health, particularly as the United States, the United ...

Famed investor Warren Buffett is donating $6 billion worth of his company's stock to five foundations, bringing the total he ...

Jared Holz, Mizuho Securities health care strategist, joins CNBC's 'Squawk on the Street' to discuss weight loss drug makers, ...

The majority (over 9.4 million shares) will go to the Gates Foundation. An additional 943,384 shares are being donated to the ...

Warren Buffett has donated $6 billion worth of his company’s stock to five foundations, bringing the total he has given to ...

The billionaire pledged in 2006 to give away most of his wealth to philanthropy. Buffett said the shares of Berkshire Hathaway will be delivered on Monday.

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...

(RTTNews) - Novo Nordisk's (NVO) Phase 3 REDEFINE 1 trial found that treatment with CagriSema led to a 22.7% weight loss at 68 weeks among patients who adhered to the treatment, compared to 2.3% ...

(Reuters) -Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that side effects were mainly mild-to-moderate and other outcome ...